Troy A. Ignelzi has bought stock on 2 days since Mar 2025

Chief Financial Officer at Rapport Therapeutics, Inc., and 1 other company

SEC CIK 0001579829 · Filings on SEC.gov ↗

$245KBought

$25.8MSold

Oct 21Last buy

Troy A. Ignelzi's record

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Companies

Every filing

23 filings since Mar 2020, newest first

RAPPBuy

Rapport Therapeutics, Inc.

Chief Financial Officer

$144K+55.0%5d ago

RAPPBuy

Rapport Therapeutics, Inc.

CFO

$101KMar 13

KRTXSell

Karuna Therapeutics, Inc.

CFO

$263K−5.0%Aug 24

KRTXSell

Karuna Therapeutics, Inc.

CFO

$2.0M−23.0%May 25

KRTXSell

Karuna Therapeutics, Inc.

CFO

$1.1M−16.0%Feb 23

KRTXSell

Karuna Therapeutics, Inc.

CFO

$205K−4.0%Jan 19

KRTXSell

Karuna Therapeutics, Inc.

CFO

$3.7M−62.0%Nov 17

KRTXSell

Karuna Therapeutics, Inc.

CFO

$3.4M−60.0%Oct 4

KRTXSell

Karuna Therapeutics, Inc.

CFO

$3.8M−40.0%Aug 11

KRTXSell

Karuna Therapeutics, Inc.

CFO

$557K−15.0%Apr 21

KRTXSell

Karuna Therapeutics, Inc.

CFO

$167K−6.0%Feb 17

KRTXSell

Karuna Therapeutics, Inc.

CFO

$2.1M−43.0%Nov 10

KRTXSell

Karuna Therapeutics, Inc.

CFO

$1.2M−36.0%Sep 10

KRTXSell

Karuna Therapeutics, Inc.

CFO

$455K−21.0%Jun 16

KRTXSell

Karuna Therapeutics, Inc.

CFO

$794K−36.0%May 12

KRTXSell

Karuna Therapeutics, Inc.

CFO

$1.2M−43.0%Feb 17

KRTXSell

Karuna Therapeutics, Inc.

CFO

$836K−38.0%Jan 12

KRTXSell

Karuna Therapeutics, Inc.

CFO

$1.1M−67.0%Nov 10

KRTXSell

Karuna Therapeutics, Inc.

CFO

$147K−29.0%Sep 10

KRTXSell

Karuna Therapeutics, Inc.

CFO

$790K−100.0%Jul 10

KRTXSell

Karuna Therapeutics, Inc.

CFO

$738K−100.0%Jun 17

KRTXSell

Karuna Therapeutics, Inc.

CFO

$625K−100.0%May 12

KRTXSell

Karuna Therapeutics, Inc.

CFO

$649K−100.0%Mar 4

Filings come from SEC EDGAR. Not investment advice.